Mycoplasma genitalium and antibiotic resistance in Spain; the need for an effective response against an emerging problem.

[1]  F. Vazquez,et al.  Impact of microbial resistance on therapeutic decisions in sexually transmitted infections. , 2018, Enfermedades infecciosas y microbiologia clinica.

[2]  J. G. Kusters,et al.  Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. , 2017, Enfermedades infecciosas y microbiologia clinica.

[3]  J. Jensen,et al.  Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013–2014 Cohort of Patients in Barcelona, Spain , 2017, Sexually transmitted diseases.

[4]  M. Unemo,et al.  Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium , 2017, Nature Reviews Urology.

[5]  M. Cusini,et al.  2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.

[6]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  A. V. van Zwet,et al.  High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. , 2015, The Journal of antimicrobial chemotherapy.

[8]  J. Papp,et al.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  E. Adams,et al.  Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.

[10]  G. Gilbert,et al.  Fluoroquinolone and Macrolide Resistance-Associated Mutations in Mycoplasma genitalium , 2013, Journal of Clinical Microbiology.